Interestingly, in the present study, the prognostic value of S6K2/4EBP1 in breast cancer was mainly restricted to tumours expressing high levels of IGFRs or HER2, indicating an important role in growth factor driven tumours. The gene discussed is ERBB2; the disease is neoplasm.